Parkinson's Disease Isradipine Safety Study
Trial
Phase 2
Completed
Nov. 14, 2021
Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
Trial
Phase 4
Completed
Nov. 8, 2021
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
Trial
Phase 4
Completed
Nov. 8, 2021
Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" Study
Trial
Phase 2
Completed
Nov. 7, 2021
Influencing Factors on Gait Variability in PD
Trial
N/A
Unknown
Nov. 4, 2021
Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?
Trial
Phase 1
Terminated
Nov. 3, 2021
Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease
Trial
N/A
Unknown
Nov. 2, 2021
A Study of CST-2032 in Subjects With Cognitive Impairment
Trial
Phase 1
Withdrawn
Oct. 27, 2021
Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease
Trial
N/A
Completed
Oct. 26, 2021
Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)
Trial
Phase 2
Completed
Oct. 26, 2021
The Effect of Cervical Spinal Stabilization Exercises in Patients With Parkinson's Disease
Trial
N/A
Completed
Oct. 25, 2021
Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
Trial
N/A
Terminated
Oct. 25, 2021
The Acute Effect of Lumbosacral Mobilization in Parkinson's Disease
Trial
N/A
Completed
Oct. 20, 2021
The Acute Effect of Cervical Mobilization in Parkinson's Disease
Trial
N/A
Completed
Oct. 20, 2021
The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease
Trial
Phase 1
Terminated
Oct. 19, 2021
Virtual Reality for Parkinson's Disease
Trial
N/A
Terminated
Oct. 18, 2021
Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease
Trial
Phase 2
Completed
Oct. 17, 2021
Comparison of Sensory Cuing Modalities for Freezing of Gait
Trial
N/A
Completed
Oct. 14, 2021